Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Sudipta Panja

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5692-450X; OpenAlex author ID A5081278977. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Tumor Lipidomic Changes after Treatment with Polymeric Hydroxychloroquine in a Syngeneic Murine Model of Pancreatic Cancer. Co-author DOI 10.1021/acsomega.5c05706↗
  2. Bioactive polymers as stimulus-responsive anti-metastatic combination agents to treat pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2025.123255↗
  3. Polymeric Chloroquine as an Effective Antimigration Agent in the Treatment of Pancreatic Cancer. First author DOI 10.1021/acs.molpharmaceut.2c00596↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Oupický · 3 shared papers, 2022–2026 · strength 0.76
  2. Rubayat Islam Khan · 2 shared papers, 2022–2025 · strength 0.40
  3. Daryl J. Murry · 1 shared paper, 2026 · strength 0.36
  4. Sai Sundeep Kollala · 1 shared paper, 2026 · strength 0.36
  5. Ling Ding · 1 shared paper, 2022 · strength 0.16
  6. Siyuan Tang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.